Emerson (NYSE:EMR) announced the expansion of its ASCO Series 090 line of miniature solenoid valves.

The product line includes a new three-way Series 090 valve configuration. The three-way configuration enables lighter, more space-efficient solutions for gas control in oxygen therapy, compression therapy and gas analyzer devices, St. Louis–based Emerson said in a news release posted yesterday.

Originally developed as a two-way valve for air and inert gases in portable medical devices, the Series 090 valve features a compact architecture, small (10.8 mm footprint and 50-million-cycle life.

Because the Series 090 valve’s new three-way configuration can perform the same mixing and diverting functions as a pair of two-way valves, it provides more design flexibility for high-precision gas delivery systems for oxygen and other home-care devices, according to Emerson.

“The introduction of the three-way Series 090 miniature solenoid valve offers product designers greater freedom to develop new valve and manifold solutions for analytical and therapeutic applications,” Sven Richter, VP of Emerson’s analytical & medical business, said in the release. “Products like the new ASCO Series 090 valve, together with Emerson’s Rapid Engineered Solutions capability, help our OEM, original-equipment-manufacturer customers to bring outstanding products to markets more quickly while improving the internal production and cost efficiencies essential to long-term competitiveness.”

The valve body is molded from polybutylene terephthalate (PBT) plastic, with seals made of durable fluorocarbon (FKM) elastomer. Emerson said the Series 090 valve also complies with all relevant Restriction of Hazardous Substances (RoHS) and Conformité Européenne (CE) directives.

Article source: medical design & outsourcing